Skip to main content
HR 235 118th Congress House Health Cancer Government information and archives Health information and medical records Health programs administration and funding Health promotion and preventive care Medical education Medical research Minority health Research administration and funding Women's health

Triple-Negative Breast Cancer Research and Education Act of 2023

Introduced: March 26, 2024 See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 118th Congress ended
It never became law before the 118th Congress (2023–2024) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jan 20, 2023
Referred to the Subcommittee on Health.
Jan 10, 2023
Referred to the House Committee on Energy and Commerce.
Jan 10, 2023
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Triple-Negative Breast Cancer Research and Education Act of 2023

This bill requires research and education activities related to triple-negative breast cancer. The cells of these breast cancers are negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so they do not respond to hormonal therapy medicines or medicines that target the HER2 protein receptors.

Specifically, the National Institutes of Health must conduct and support research into the disease.

Additionally, the Centers for Disease Control and Prevention and the Health Resources and Services Administration must develop information about triple-negative breast cancer, including information regarding the elevated risk for minority women, for the public and for health care providers.

What's happening now January 20, 2023

Referred to the Subcommittee on Health.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 11
All 11 Democratic 10 Republican 1
D
Sewell, Terri A.
Alabama · Jul 15, 2024
 D
Moskowitz, Jared
Florida · Mar 26, 2024
 D
Jackson, Jonathan L.
Illinois · Mar 21, 2024
 D
Carter, Troy A.
Louisiana · Nov 6, 2023
 D
Evans, Dwight
Pennsylvania · Oct 26, 2023
 D
Ivey, Glenn
Maryland · Oct 25, 2023
 D
Williams, Nikema
Georgia · Oct 18, 2023
 D
Tonko, Paul
New York · Oct 16, 2023
 R
Bacon, Don
Nebraska · Oct 11, 2023
 D
Morelle, Joseph D.
New York · Oct 11, 2023
 D
Moore, Gwen
Wisconsin · Oct 10, 2023
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 235: Triple-Negative Breast Cancer Research and Education Act of 2023. 118th Congress. Open America. https://openamerica.io/bill/118-HR-235/
MLA
"H.R. 235: Triple-Negative Breast Cancer Research and Education Act of 2023." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-HR-235/.
Bluebook (legal)
H.R. 235, 118th Cong. (2026), https://openamerica.io/bill/118-HR-235/.
Markdown link
[H.R. 235: Triple-Negative Breast Cancer Research and Education Act of 2023](https://openamerica.io/bill/118-HR-235/)
Report a problem